Nephrology Grand Rounds: SGLT2 Inhibitors
medcases00
Published on Aug 22, 2021
Prof Heerspink from UMC Groningen presented at Nephrology Grand Rounds on December 17th 2020
The topic was Flozination, ie the use of SGLT2 inhibitors, in not just type 2 diabetes, but in non-diabetic CKD
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
53:09SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
12 views 1043 days ago -
Watch Later
55:16 -
Watch Later
34:00 -
Watch Later
![Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury]()
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
11 views 612 days ago -
Watch Later
![Peritoneal Dialysis for the Non-Nephrologist (ECU Internal Medicine Grand Rounds)]()
54:25Peritoneal Dialysis for the Non-Nephrologist (ECU Internal Medicine Grand Rounds)
14 views 1071 days ago -
Watch Later
![Hematology and Medical Oncology Grand Rounds - June 25, 2020]()
36:18Hematology and Medical Oncology Grand Rounds - June 25, 2020
12 views 1044 days ago
